期刊文献+

氯胺酮上调GSK-3β活性加重Aβ_(25-35)诱导的大鼠PC12细胞Tau蛋白过度磷酸化 被引量:2

Ketamine aggravates Tau hyperphosphorylation by up-regulating activity of GSK-3β in Aβ_(25-35 )induced PC12 cells
下载PDF
导出
摘要 目的探讨氯胺酮对凝聚态Aβ25-35诱导的大鼠肾上腺嗜铬细胞瘤细胞(PC12)Tau蛋白过度磷酸化的影响及可能作用的机制。方法将培养的PC12细胞随机分为对照组(C)、10μmol/L Aβ25-35(A组)、1 mmol/L氯胺酮(K组)、氯胺酮和Aβ25-35(AK组),作用时间均为6 h。MTT比色法测定细胞活力,蛋白免疫印迹检测Tau蛋白不同磷酸化位点和糖原合成激酶3β(GSK-3β)在Ser9位点的磷酸化(p-GSK-3βSer9)相对于GSK-3β的表达水平,用GSK-3β特异性抑制剂氯化锂(LiCl)干预。结果 AK组的细胞存活率显著低于其余组;Tau蛋白在Ser396、Ser404和Thr231位点的磷酸化水平显著高于A组(P<0.05)。LiCl可通过增加p-GSK-3βSer9的表达抑制上述变化。结论氯胺酮通过上调GSK3β的活性增加Aβ25-35诱导的大鼠PC12细胞Tau蛋白过度磷酸化。 Objective To find potential effect of ketamine can induce Tau hyperphosphorylation by increasing activity of glycogen synthase kinase-3β(GSK-3β) in Aβ25-35 induced PC12 cells.Methods We performed these studies in cultured rat pheochromocytoma cells(PC12) and randomly allocated PC12 cells into four groups: control group(C),10 μmol/L Aβ25-35(A),1 mmol/L ketamine(K),Aβ25-35 and ketamine(AK).All groups were incubated for 6 hours.The cell viability was determined by MTT assay.Western blot was performed to observe the protein expression of Tau phosphorylation of different sites,GSK-3β and p-GSK-3βSer9.In addition,lithium chloride,inhibitor of GSK-3β,was administered to all above groups to investgate the changes of protein expression.Results Thecell survival rate was significantly decreased in AK group as compared with the others groups.The level of Tau phosphorylation in the sites of Ser396,Ser404 and Thr231 increased after intubation with ketamine and Aβ25-35.And these increases were accompanied by up-regulation of activity of GSK-3β.Lithium chloride attenuates these changes above all.Conclusion Ketamine increases Tau hyperphosphorylation by up-regulating activity of GSK-3β in Aβ25-35 induced PC12 cells.
出处 《基础医学与临床》 CSCD 北大核心 2011年第5期509-514,共6页 Basic and Clinical Medicine
基金 国家自然科学基金(30872425) 山东省教育厅国内访问学者项目(BK2001132)
关键词 氯胺酮 TAU蛋白 PC12细胞 β淀粉样蛋白多肽片段25-35 GSK-3Β ketamine Tau protein PC12 cell beta-amyloid peptide25-35 GSK-3β
  • 相关文献

参考文献15

  • 1Morgan C J, Mofeez A, Brandaer B, et al. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers [ J ]. Neuro Psychopharmacol, 2004, 29:208-218.
  • 2Taffe MA, Davis SA, Gutierrez T, et al. Ketamine impairs multiple cognitive domains in rhesus monkeys [ J ]. Drag Alcohol Depend, 2002, 68:175 - 187.
  • 3Immelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury [ J]. Anesth Analg,2005, 101 : 524 -534.
  • 4Huang HC, Jiang ZF. Accumulated amyloid-beta peptide and hyperphosphorylated tan protein: relationship and links in Alzheimer's disease [ J ]. J Alzheimer's Dis, 2009, 16 : 15 - 27.
  • 5陈晨,桂波,钱燕宁.不同剂量氯胺酮对老年大鼠认知功能的影响[J].中华麻醉学杂志,2008,28(7):590-593. 被引量:13
  • 6戴泽平,田玉科,汪辉,朱美芳,杨定东,王海.氯胺酮对幼年大鼠海马神经元tau蛋白磷酸化水平的影响[J].中华麻醉学杂志,2008,28(1):60-62. 被引量:7
  • 7Bancher C, Brunner C, Lassmenn H, et al. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease [ J ]. Brain Res, 1989, 477:90 - 99.
  • 8Holzer M, Hozapfel HP, Zedlick D, et al. Abnormally phosphorylated tau protein in Alzheimer's disease: heteroge- neity of individual regional distribution and relationship to clinical severity [J]. Neuroscience, 1994, 63:499-516.
  • 9Wilcock DM, Gharkholonarehe N, Van nostrand WE, et al. Amyloid reduction by amyloid-beta vaccination also re- duces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease [ J ]. J Neurosci, 2009, 29 : 7957 - 7965.
  • 10Rebeck GW, Hoe HS, Moussa CE. beta-Amyloid1-42 gene transfer model exhibits intraneuronal amyloid, glio- sis, tau phosphorylation, and neuronal loss [ J ]. J Biol Chem, 2010, 285:7440-7446.

二级参考文献34

  • 1王贤裕,田玉科,杨辉,安珂.腹腔重复注射小剂量氯胺酮术后镇痛对趾部切口术大鼠认知功能的影响[J].中华麻醉学杂志,2005,25(3):205-207. 被引量:18
  • 2刘毓和,吴新民,杜敏逸.咪唑安定、异丙酚和氯胺酮对老年大鼠认知功能的影响[J].中华麻醉学杂志,2006,26(4):315-317. 被引量:51
  • 3Rohan D, Buggy D J, Crowley S, et al. Increased incidence of postoperative cognitive dysfunction 24 hr after minor surgery in the elderly. Can J Anaesth, 2005,52: 137-142.
  • 4Abildstrom H, Rasmussen IS, Rentowl P, et al. Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthosiol Scand, 2000, 44 : 1246-1251.
  • 5Morgan C J, Mofeez A, Brandner B, et al. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology, 2004,29:208-218.
  • 6Hayashi H, Dikkes P, Soriano SG. Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth, 2002, 12:770-774.
  • 7Guillozet AL, Weintraub S, Mash DC, et al. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol, 2003, 60:729-736.
  • 8Jevtovic-Todorovic V, Wozniak DF, Benshof ND,et al. A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide. Brain Res, 2001, 895 (1-2) : 264-267.
  • 9Buerger K, Zinkowski R, Teipel SJ, et al. Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol, 2002, 59:1267-1272.
  • 10Liu SJ, Zhang AH, Li HL, et al. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J Neuroehem, 2003, 87: 1333-1344.

共引文献18

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部